Join us at Immunology To Change Lives on Tuesday, November 17, 2026!
At BRI, we know that progress against one immune system disease is progress against them all. From studying genes to understand why some people are at higher risk for diseases of the immune system, to exploring therapies that delay the onset of disease, our research fuels groundbreaking discoveries that impact the real people living with these conditions. We take what we learn in the lab and integrate it into clinical care. Just as importantly, we take the challenging questions and lived experiences from patients and bring them back into the lab. By studying every step on the path to disease, we move closer to uncovering ways to bring people back to health, achieving our mission of a healthy immune system for all. Research at BRI is deeply interconnected, creating detailed pictures of the immune system in health and disease, to move forward our mission of advancing the science to predict, prevent, reverse and cure diseases of the immune system.
Featured Speakers
News
Why are Autoimmune Diseases So Prevalent in Women?
Read More
Benaroya Research Institute Awarded 16 Million Across 18 Grants in First Half of 2026 to Predict, Prevent, Reverse and Cure Immune System Diseases
Read More
Seattle Children’s Research Institute, Benaroya Research Institute at Virginia Mason Franciscan Health, and GentiBio Highlight Long Standing Scientific Collaboration Advancing GNTI 122 Into the Clinic
Read More
Innovation Fund Spotlight: Finding the Precise Moment When Immune Cells Start Causing Disease
Autoimmune diseases happen when immune cells, which are supposed to protect you from germs, mistakenly attack healthy tissues. But what if we knew exactly which immune cells would attack – and when? Could we stop that attack before it starts?
Game-Changing Treatment for T1D Enters Clinical Trials
A new T1D treatment, built on decades of research at BRI and other institutions, has entered human clinical trials.
Innovation Fund Spotlight: Pioneering a New Generation of Tetramers
In the late 1990s, Bill Kwok, PhD, pioneered MHC class II tetramers, a game-changing tool in immunology research. Tetramers have fueled countless research breakthroughs because they enable scientists to find extremely rare cells and extract them to study in precise detail.
Questions?
Contact us via email. We're happy to answer any questions you may have.
